[
  {
    "ts": null,
    "headline": "1 Healthcare Stock to Own for Decades and 2 We Avoid",
    "summary": "Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. But speed bumps such as inventory destockings have persisted in the wake of COVID-19, limiting growth. This has capped returns as the industry’s six-month gain of 11.6% has lagged the S&P 500’s 16.3% climb.",
    "url": "https://finnhub.io/api/news?id=d18bee16e96f84b00e5990a016d377a6ca9f3c6e474b811c6a47950c85d6f610",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1763095308,
      "headline": "1 Healthcare Stock to Own for Decades and 2 We Avoid",
      "id": 137478325,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "COR",
      "source": "Yahoo",
      "summary": "Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. But speed bumps such as inventory destockings have persisted in the wake of COVID-19, limiting growth. This has capped returns as the industry’s six-month gain of 11.6% has lagged the S&P 500’s 16.3% climb.",
      "url": "https://finnhub.io/api/news?id=d18bee16e96f84b00e5990a016d377a6ca9f3c6e474b811c6a47950c85d6f610"
    }
  }
]